Skip to main content
SpringerLink
Log in

Polmonite interstiziale fibrosante da amiodarone

  • TIROIDE
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Bibliografia

  1. Bartalena L, Bogazzi F, Chiovato L et al. (2018) European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J 7(2):55–66

    Article  CAS  Google Scholar 

  2. Cappellani D, Bogazzi F (2019) Gestione clinica della tireopatia da amiodarone. Endocrinologo 20(Suppl 1):46

    Article  Google Scholar 

  3. Vassallo P, Trohman RG (2007) Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 298:1312–1322

    Article  CAS  Google Scholar 

  4. Gao S, Dai W, Zhang L et al. (2013) Risk of cardiovascular events, stroke, congestive heart failure, interstitial lung disease and acute liver injury: dronedarone versus amiodarone and other antiarrthythmics. J Atr Fibrillation 6(4):890

    PubMed  PubMed Central  Google Scholar 

  5. Schwaiblmair M, Berghaus T, Haeckel T et al. (2010) Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect? Clin Res Cardiol 99:693–700

    Article  CAS  Google Scholar 

  6. Wolkove N, Baltzan M (2009) Amiodarone pulmonary toxicity. Can Respir J 16:43–48

    Article  CAS  Google Scholar 

  7. Yamada Y, Shiga T, Matsuda N et al. (2007) Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone. Circ J 71:1610–1616

    Article  CAS  Google Scholar 

  8. Stewart JJ, Chawla R (2008) Amiodarone pneumonitis. Respir Care 53:370–375

    PubMed  Google Scholar 

  9. Mankikian J, Favelle O, Guillon A et al. (2014) Initial characteristics and outcome of hospitalized patients with amiodarone pulmonary toxicity. Respir Med 108:638–646

    Article  CAS  Google Scholar 

  10. Light RW, Lee G (2016) Pleural diseases, 3rd edn. CRC Press, Boca Raton, p 387

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pneumologia, AOU Policlinico “Gaetano Martino”, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italia

    Domenica Catalano, Paolo Ruggeri & Gaetano Caramori

  2. UOC di Diagnostica per Immagini, AOU Policlinico “Gaetano Martino”, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italia

    Ignazio Salamone

Authors
  1. Domenica Catalano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paolo Ruggeri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ignazio Salamone
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gaetano Caramori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gaetano Caramori.

Ethics declarations

Conflitto di interesse

Gli autori Domenica Catalano, Paolo Ruggeri, Ignazio Salamone e Gaetano Caramori dichiarano di non avere conflitti di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Gli autori di questo articolo non hanno eseguito studi sugli animali.

Additional information

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Catalano, D., Ruggeri, P., Salamone, I. et al. Polmonite interstiziale fibrosante da amiodarone. L'Endocrinologo 21 (Suppl 1), 78–80 (2020). https://doi.org/10.1007/s40619-020-00717-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-020-00717-z

Search

Navigation